Medtronic PLC
(NYSE : MDT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
-0.25%74.810.8%$458.80m
MDTMedtronic PLC
0.33%92.640.6%$456.17m
ISRGIntuitive Surgical, Inc.
-0.29%546.582.4%$423.50m
TMOThermo Fisher Scientific Inc.
-0.07%250.651.0%$387.56m
ALGNAlign Technology, Inc.
-0.73%253.386.3%$367.72m
SYKStryker Corporation
0.36%186.791.3%$325.21m
BSXBoston Scientific Corporation
0.10%39.901.1%$286.12m
BDXBecton, Dickinson and Company
-0.07%247.881.1%$254.45m
BAXBaxter International Inc.
0.03%73.491.7%$212.56m
EWEdwards Lifesciences Corporation
-0.11%176.831.2%$209.84m
ABMDABIOMED, Inc.
-0.25%358.463.3%$201.31m
WATWaters Corporation
-0.52%233.223.5%$181.19m
ZBHZimmer Biomet Holdings, Inc.
0.20%123.811.7%$176.71m
DXCMDexCom, Inc.
-0.51%147.148.5%$155.84m
IDXXIDEXX Laboratories, Inc.
0.04%211.403.7%$109.73m

Company Profile

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.